Correlation study of CAR, PLR, NLR with the prognosis of cardiogenic cerebral embolism patients
- PMID: 40599820
- PMCID: PMC12208937
- DOI: 10.3389/ebm.2025.10517
Correlation study of CAR, PLR, NLR with the prognosis of cardiogenic cerebral embolism patients
Abstract
This study explored the association between inflammatory biomarkers-C-reactive protein to albumin ratio (CAR), platelet to lymphocyte ratio (PLR), and neutrophil to lymphocyte ratio (NLR)-and the prognosis of patients with cardiogenic cerebral embolism (CCE). We retrospectively analyzed data from 80 CCE patients diagnosed between June 2020 and June 2024, categorizing them into favorable and unfavorable prognosis groups based on outcomes such as death, recurrence, and disability. The CAR, PLR, and NLR values were calculated from routine blood tests, and statistical analyses, including Spearman correlation, multivariate logistic regression, and ROC curve analysis, were performed to examine their prognostic significance. Results showed that the unfavorable prognosis group had significantly higher CAR, PLR, and NLR values compared to the favorable group (P < 0.05). Spearman correlation analysis revealed positive associations between these biomarkers and prognosis (r = 0.319 for CAR, 0.238 for PLR, 0.251 for NLR, all P < 0.05). Multivariate analysis identified CAR and NLR as independent risk factors for unfavorable prognosis (OR = 1.034 for CAR, OR = 3.887 for NLR). ROC analysis determined optimal cutoff values for CAR (>0.74), PLR (>160.00), and NLR (>3.53) to predict unfavorable prognosis with AUCs of 0.796, 0.694, and 0.705, respectively. The combined biomarker test yielded an AUC of 0.899. Kaplan-Meier survival analysis indicated significantly lower survival rates for patients with higher levels of CAR, PLR, and NLR (P < 0.05). In conclusion, elevated CAR, PLR, and NLR are reliable indicators of a poor prognosis in CCE patients.
Keywords: CAR; NLR; PLR; cardiogenic cerebral embolism; prognosis.
Copyright © 2025 Du, Li, Yue, Sun, Zhao, Zhou, Wang and Yang.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures




Similar articles
-
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.Int J Chron Obstruct Pulmon Dis. 2024 Apr 15;19:933-943. doi: 10.2147/COPD.S452444. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38646605 Free PMC article.
-
Application value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting stress ulcer after acute cerebral hemorrhage surgery.Clin Neurol Neurosurg. 2024 Nov;246:108557. doi: 10.1016/j.clineuro.2024.108557. Epub 2024 Sep 16. Clin Neurol Neurosurg. 2024. PMID: 39303663
-
Relationship between lymphocyte-related parameters and the prognosis of patients with lupus nephritis.Front Immunol. 2025 Jul 8;16:1613483. doi: 10.3389/fimmu.2025.1613483. eCollection 2025. Front Immunol. 2025. PMID: 40698075 Free PMC article.
-
Association between the immune-inflammation index and the severity and clinical outcomes of patients with inflammatory bowel disease: a systematic review and meta-analysis.BMC Gastroenterol. 2025 May 29;25(1):414. doi: 10.1186/s12876-025-04033-4. BMC Gastroenterol. 2025. PMID: 40442599 Free PMC article.
-
Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.Cell Physiol Biochem. 2017;44(3):967-981. doi: 10.1159/000485396. Epub 2017 Nov 27. Cell Physiol Biochem. 2017. PMID: 29179180
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials